Hui Tang - Acton MA, US Lisa Rogers - Londonderry NH, US Joseph Ferraro - Londonderry NH, US Paul Martakos - Pelham NH, US Steven A. Herweck - Wellesley MA, US Theodore Karwoski - Hollis NH, US
- Merrimack NH, US Hui TANG - Acton MA, US Paul MARTAKOS - Pelham NH, US Theodore KARWOSKI - Moultonborough NH, US Alison SULLIVAN - Acton MA, US Greg MELVILLE - Hudson NH, US Scott E. CORBEIL - Litchfield NH, US
Assignee:
ATRIUM MEDICAL CORPORATION - Merrimack NH
International Classification:
A61L 31/08 A61L 31/16 A61K 31/4353 A61L 31/14
Abstract:
Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.
- Southborough MA, US Hui Tang - Acton MA, US Judy Walish - West Roxbury MA, US
International Classification:
A61M 27/00 A61M 25/04
Abstract:
Disclosed herein is ureteral stent. The ureteral stent includes a proximal end, a distal end, and a middle portion. The proximal end includes a retention feature having a coiled shape. The distal end is opposite the proximal end. The middle portion is between the proximal end and the distal end.
- Merrimack NH, US Hui TANG - Acton MA, US Joseph FERRARO - Londonderry NH, US Paul MARTAKOS - Pelham NH, US Theodore KARWOSKI - Hollis NH, US Scott CORBEIL - Litchfield NH, US
Fatty acid-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.
- Southborough MA, US Hui Tang - Acton MA, US Thomas J. Holman - Princeton MN, US
Assignee:
Gyrus ACMI, Inc. d/b/a Olympus Surgical Technologies America - Southborough MA
International Classification:
A61M 27/00 A61F 2/04 A61L 31/04
Abstract:
A ureteral stent is provided. The stent may include a first section having a first wall defining a first luminal section. The stent may further include a second section having a second wall defining a second luminal section. The second section can be enabled to substantially close at times external pressure is applied to the stent.
- Southborough MA, US Hui Tang - Acton MA, US Judy Walish - West Roxbury MA, US
International Classification:
A61M 27/00 A61M 25/04
Abstract:
Disclosed herein is ureteral stent. The ureteral stent includes a proximal end, a distal end, and a middle portion. The proximal end includes a retention feature having a coiled shape. The distal end is opposite the proximal end. The middle portion is between the proximal end and the distal end.
- Merrimack NH, US Hui TANG - Acton MA, US Paul MARTAKOS - Pelham NH, US Theodore KARWOSKI - Hollis NH, US Allison SULLIVAN - Acton MA, US Greg MELVILLE - Hudson NH, US Scott E. CORBEIL - Litchfield NH, US
Assignee:
ATRIUM MEDICAL CORPORATION - Merrimack NH
International Classification:
A61L 31/08 A61L 31/14
Abstract:
Fatty acid-based, pre-cure-derived biomaterials, methods of making the biomaterials, and methods of using them as drug delivery carriers are described. The fatty acid-derived biomaterials can be utilized alone or in combination with a medical device for the release and local delivery of one or more therapeutic agents. Methods of forming and tailoring the properties of said biomaterials and methods of using said biomaterials for treating injury in a mammal are also provided.
Provided are methods, systems, and kits of properly delivering a biodegradable stent into a body lumen of a subject. More particularly, provided are methods, systems, and kits of properly delivering a biodegradable ureteral stent into the kidney and the bladder of a subject. Even more particularly, provided are methods, systems, and kits of properly delivering a chitosan based stent into a body lumen of a subject. Even more particularly, provided are methods, systems, and kits of properly delivering a chitosan based ureteral stent into the kidney and the bladder of a subject.
Dr. Tang graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1983. She works in Fleming Island, FL and specializes in Family Medicine. Dr. Tang is affiliated with Orange Park Medical Center.